Search results
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted...
Newswise· 4 days agoMD Anderson and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug (IND) appli
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 4 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Lawmakers honor popular Kansas City DJ following cancer death
KCTV 5 Kansas City· 3 days agoA popular Kansas City radio DJ is gone, but memories of his laughter and spirit live on through a...
Cullinan Oncology (NASDAQ:CGEM) Now Covered by Stifel Nicolaus
ETF DAILY NEWS· 13 hours agoAnalysts at Stifel Nicolaus initiated coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The brokerage set ...
Syros Pharmaceuticals (NASDAQ:SYRS) Stock Price Passes Below 50 Day Moving Average of $5.94
ETF DAILY NEWS· 2 days agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 ...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 3 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies Phase 1/2 study in patients with relapsed/refractory AML
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Holdings Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 2 days agoRussell Investments Group Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 84.5% during the fourth quarter, according to its most recent Form 13F filing with ...
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Of Texas/Texas Am I. University Sells...
ETF DAILY NEWS· 2 days agoAileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) major shareholder Of Texas/Texas Am I. University sold 20,315 shares of Aileron Therapeutics stock in a transaction that occurred on ...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition
Investing.com· 5 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...